| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 1.080 | 0 | 0 | 376.448 | 456.414 |
| Total Income - EUR | - | - | - | - | - | 1.080 | 0 | 7 | 384.884 | 477.681 |
| Total Expenses - EUR | - | - | - | - | - | 2.031 | 1.529 | 1.180 | 7.643 | 22.145 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -951 | -1.529 | -1.173 | 377.240 | 455.535 |
| Net Profit/Loss - EUR | - | - | - | - | - | -980 | -1.529 | -1.173 | 327.016 | 388.931 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Rx Track & Trace S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 1.800 | 807 | 268 | 0 | 3 |
| Current Assets | - | - | - | - | - | 5.453 | 4.733 | 4.143 | 361.823 | 452.859 |
| Inventories | - | - | - | - | - | 468 | 458 | 459 | 0 | 0 |
| Receivables | - | - | - | - | - | 634 | 388 | 389 | 154.465 | 336.707 |
| Cash | - | - | - | - | - | 4.351 | 3.887 | 3.295 | 207.357 | 116.152 |
| Shareholders Funds | - | - | - | - | - | 7.290 | 5.599 | 4.443 | 331.446 | 398.581 |
| Social Capital | - | - | - | - | - | 8.269 | 8.086 | 8.111 | 8.087 | 8.041 |
| Debts | - | - | - | - | - | 11 | 13 | 0 | 30.429 | 54.356 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5829 - 5829" | |||||||||
| CAEN Financial Year |
5829
|
|||||||||
Comments - Rx Track & Trace S.r.l.